Total Payments
$16,467
2024 Payments
$1,862
Companies
57
Transactions
711
Medicare Patients
11,666
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$15,137 (91.9%)
Travel$674.12 (4.1%)
Education$448.44 (2.7%)
Consulting$207.49 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,137 | 694 | 91.9% |
| Travel and Lodging | $674.12 | 2 | 4.1% |
| Education | $448.44 | 14 | 2.7% |
| Consulting Fee | $207.49 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,339 | 54 | $0 (2024) |
| Astellas Pharma US Inc | $1,439 | 75 | $0 (2023) |
| COLOPLAST CORP | $1,280 | 59 | $0 (2024) |
| ABBVIE INC. | $1,112 | 60 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $902.65 | 26 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $803.28 | 42 | $0 (2024) |
| Allergan, Inc. | $713.48 | 31 | $0 (2022) |
| Janssen Biotech, Inc. | $654.40 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $624.66 | 35 | $0 (2024) |
| NeoTract Inc. | $526.11 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,862 | 83 | Sumitomo Pharma America, Inc. ($214.40) |
| 2023 | $2,446 | 96 | Sumitomo Pharma America, Inc. ($588.88) |
| 2022 | $2,262 | 111 | Boston Scientific Corporation ($420.41) |
| 2021 | $2,354 | 97 | BOSTON SCIENTIFIC CORPORATION ($418.06) |
| 2020 | $1,095 | 54 | Astellas Pharma US Inc ($266.23) |
| 2019 | $1,704 | 80 | Janssen Biotech, Inc. ($393.57) |
| 2018 | $2,047 | 99 | BOSTON SCIENTIFIC CORPORATION ($318.77) |
| 2017 | $2,697 | 91 | BOSTON SCIENTIFIC CORPORATION ($681.73) |
All Payment Transactions
711 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | LANTHEUS MEDICAL IMAGING, INC. | — | Food and Beverage | In-kind items and services | $21.94 | General |
| 12/04/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $43.72 | General |
| Category: Pain Management | ||||||
| 11/27/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Men's Health | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: HORMONE THERAPY | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.56 | General |
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/21/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: BLADDER | ||||||
| 10/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/11/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: WOMENS HEALTH | ||||||
| 10/09/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $18.23 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | LANTHEUS MEDICAL IMAGING, INC. | — | Food and Beverage | In-kind items and services | $25.83 | General |
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 3,379 | 11,405 | $1.4M | $413,570 |
| 2022 | 40 | 2,867 | 8,597 | $1.2M | $365,454 |
| 2021 | 37 | 3,160 | 9,012 | $1.2M | $386,575 |
| 2020 | 35 | 2,260 | 7,718 | $1.0M | $291,647 |
Total Patients
11,666
Total Services
36,732
Medicare Billing
$1.5M
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 18 | 924 | $177,408 | $61,891 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 490 | 619 | $138,960 | $57,046 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 405 | 505 | $73,575 | $33,903 | 46.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 94 | 649 | $49,761 | $32,092 | 64.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 27 | 210 | $207,648 | $27,457 | 13.2% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 53 | 767 | $44,870 | $26,376 | 58.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 22 | 4,900 | $59,325 | $24,163 | 40.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 115 | 126 | $103,506 | $23,256 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $40,196 | $13,207 | 32.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 153 | 203 | $41,200 | $13,079 | 31.7% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 22 | 30 | $28,906 | $9,855 | 34.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 30 | 30 | $29,640 | $8,276 | 27.9% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 53 | 118 | $13,806 | $8,118 | 58.8% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 25 | 25 | $44,375 | $7,181 | 16.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 30 | 30 | $26,530 | $5,959 | 22.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 13 | 13 | $17,250 | $4,864 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $12,049 | $4,258 | 35.3% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 53 | 118 | $6,903 | $4,058 | 58.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 34 | 34 | $16,476 | $3,882 | 23.6% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 24 | 27 | $11,232 | $3,418 | 30.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 314 | 393 | $29,490 | $3,298 | 11.2% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 19 | 19 | $21,280 | $3,078 | 14.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 45 | 48 | $18,080 | $2,979 | 16.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 29 | $6,728 | $2,887 | 42.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 39 | 40 | $9,405 | $2,822 | 30.0% |
About Dr. Grant Chavin, MD
Dr. Grant Chavin, MD is a Specialist healthcare provider based in Homewood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548284730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grant Chavin, MD has received a total of $16,467 in payments from pharmaceutical and medical device companies, with $1,862 received in 2024. These payments were reported across 711 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($15,137).
As a Medicare-enrolled provider, Chavin has provided services to 11,666 Medicare beneficiaries, totaling 36,732 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Homewood, IL
- Active Since 07/27/2006
- Last Updated 04/16/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1548284730
Products in Payments
- BOTOX (Biological) $1,090
- GREENLIGHT (Device) $863.02
- GEMTESA (Drug) $781.61
- XTANDI (Drug) $676.91
- PROLARIS (Device) $657.89
- XIAFLEX (Biological) $552.73
- ORGOVYX (Drug) $541.44
- Urolift - UL400 (Device) $526.11
- PROVENGE (Drug) $502.58
- Erleada (Drug) $465.24
- SPEEDICATH (Device) $390.78
- Xofigo (Drug) $331.86
- REZUM (Device) $323.35
- Nubeqa (Drug) $292.80
- AQUABEAM ROBOTIC SYSTEM (Device) $286.16
- Myrbetriq (Drug) $282.79
- LUPRON DEPOT (Drug) $272.98
- Trelstar (Drug) $258.58
- LITHOVUE (Device) $251.88
- Prolaris (Device) $244.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Homewood
Francois Blaudeau, M.d, M.D
Specialist — Payments: $29,257
Specialist $29,257
Dr. Venkata Uppuluri, M.d, M.D
Specialist — Payments: $982.10
Specialist $982.10
Ms. Leslea Shamp, Pt, PT
Specialist
Specialist
Mrs. Christa Mann, Otr L, Cht, OTR L, CHT
Specialist
Specialist
Dr. Nour Malak, D.n, D.N
Specialist
Specialist
Dr. Cindy Boyer, D.n, D.N
Specialist
Specialist